LAGUNA HILLS, California, Nov. 13, 2020 /PRNewswire/ — Adagio Medical, Inc., a leading innovator for the treatment of atrial
fibrillation (AF) and ventricular tachycardia (VT), and developer of the intelligent Continuous Lesion Ablation System (iCLAS), today announced that it has
closed a $42.5 million Series E equity financing.  Proceeds from the financing will be used to support